# Phase 4 Study of Laybon Tab. in Knee Osteoarthritis

> **NCT07203547** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Mather's Pharm. Co., Ltd.** · enrollment: 172 (estimated)

## Conditions studied

- Osteoarthritis, Knee
- Osteoarthritis

## Interventions

- **DRUG:** Layla Tab.
- **DRUG:** Laybon Tab.

## Key facts

- **NCT ID:** NCT07203547
- **Lead sponsor:** Mather's Pharm. Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12
- **Primary completion:** 2027-12
- **Final completion:** 2028-03
- **Target enrollment:** 172 (ESTIMATED)
- **Last updated:** 2025-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07203547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07203547, "Phase 4 Study of Laybon Tab. in Knee Osteoarthritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07203547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*